We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+21.59%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$755M
AUM Growth
-$233M
Cap. Flow
-$241M
Cap. Flow %
-31.95%
Top 10 Hldgs %
44.11%
Holding
104
New
30
Increased
5
Reduced
45
Closed
18

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$4.01M
2
AKYA
Akoya BioSciences
AKYA
+$2.41M
3
ABCM
Abcam PLC
ABCM
+$2.17M
4
ATEC icon
Alphatec Holdings
ATEC
+$2.07M
5
AMN icon
AMN Healthcare
AMN
+$1.89M

Top Sells

Rank Stock Value
1
QTRX icon
Quanterix
QTRX
+$22.5M
2
ESTA icon
Establishment Labs
ESTA
+$16.1M
3
GKOS icon
Glaukos
GKOS
+$15.8M
4
INSP icon
Inspire Medical Systems
INSP
+$11.3M
5
LIVN icon
LivaNova
LIVN
+$8.95M

Sector Composition

Rank Sector Weight
1 Healthcare 30.02%
2 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDX icon
26
PUT
VanEck Gold Miners ETF
GDX
$27.5B
$9.54M 1.26%
121,100
-228,900
-65% -$7.46M
SWAV
27
PUT
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$8.51M 1.13%
+29,800
New +$8.28M
LUNG icon
28
Pulmonx
LUNG
$97.1M
$8.34M 1.11%
636,408
-1,105
-0.2% -$13.5K
RMD icon
29
PUT
ResMed
RMD
$32.6B
$7.67M 1.02%
35,100
-14,900
-30% -$3.32M
ISRG icon
30
CALL
Intuitive Surgical
ISRG
$142B
$7.39M 0.98%
21,600
-18,400
-46% -$5.57M
RCEL icon
31
Avita Medical
RCEL
$254M
$7.25M 0.96%
426,321
-372,601
-47% -$5.47M
SILK
32
PUT
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$7.15M 0.95%
+220,100
New +$8.04M
ILMN icon
33
CALL
Illumina
ILMN
$29.1B
$7.05M 0.93%
38,653
-38,447
-50% -$7.78M
DENT
34
CALL
DELISTED
AdvisorShares Dent Tactical ETF
DENT
$6.94M 0.92%
+1,253,400
New +$6.94M
MEDP icon
35
PUT
Medpace
MEDP
$16.9B
$6.77M 0.9%
+28,200
New +$5.86M
SONX
36
DELISTED
Sonendo, Inc.
SONX
$6.35M 0.84%
4,672,145
+130,340
+3% +$177K
INMD icon
37
PUT
InMode
INMD
$870M
$6.33M 0.84%
169,400
-230,600
-58% -$8.06M
LYRA
38
DELISTED
LYRA THERAPEUTICS INC
LYRA
$5.72M 0.76%
28,265
-11,674
-29% -$1.62M
BSX icon
39
CALL
Boston Scientific
BSX
$74.2B
$5.37M 0.71%
+99,300
New +$5.19M
ABT icon
40
PUT
Abbott
ABT
$190B
$5.28M 0.7%
48,400
-151,600
-76% -$16.2M
GH icon
41
Guardant Health
GH
$22.2B
$5M 0.66%
+139,591
New +$4.01M
APYX icon
42
Apyx Medical
APYX
$127M
$4.97M 0.66%
988,594
-482,664
-33% -$2.45M
BAX icon
43
CALL
Baxter International
BAX
$14.3B
$4.37M 0.58%
+96,000
New +$4.18M
TELA icon
44
TELA Bio
TELA
$35.4M
$4.07M 0.54%
402,016
+30,207
+8% +$309K
ALC icon
45
PUT
Alcon
ALC
$36.7B
$3.97M 0.53%
48,400
-36,600
-43% -$2.8M
NSTG
46
DELISTED
NanoString Technologies, Inc.
NSTG
$3.97M 0.53%
981,043
-345,907
-26% -$2.55M
IRTC icon
47
PUT
iRhythm Holdings
IRTC
$4.02B
$3.93M 0.52%
+37,700
New +$4.53M
TFX icon
48
PUT
Teleflex
TFX
$5.91B
$3.63M 0.48%
15,000
-15,000
-50% -$3.76M
LNTH icon
49
CALL
Lantheus
LNTH
$6.57B
$3.3M 0.44%
39,300
-7,500
-16% -$673K
A icon
50
PUT
Agilent Technologies
A
$42.2B
$3.15M 0.42%
26,200
-23,800
-48% -$3.03M
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2023 Portfolio in Review

As of Q2 2023, Pura Vida Investments held 104 positions worth $755M, down 24% from $988M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Pura Vida Investments withdrew a net $241M in Q2 2023, closing 18 positions and reducing 45 holdings. Its most notable exit was Transmedics, an estimated $4.17M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Industrials.

Against the trend, Pura Vida Investments opened a new position in Guardant Health worth $5M.

  • Pura Vida Investments's largest Q2 2023 buy was Guardant Health: 139,591 shares worth $5M.
  • Pura Vida Investments added most to Cutera, Inc. in Q2 2023, an estimated $819K increase.
  • Pura Vida Investments's biggest Q2 2023 reduction was Quanterix, cutting an estimated $22.5M.
  • Pura Vida Investments fully exited Transmedics in Q2 2023, selling an estimated $4.17M.
  • Pura Vida Investments's ten largest holdings make up 44% of its $755M portfolio in Q2 2023.
  • Pura Vida Investments opened 30 new positions and closed 18 in Q2 2023.
  • Pura Vida Investments's portfolio value fell 24% quarter-over-quarter to $755M.

Based on Pura Vida Investments's 13F filing for Q2 2023, filed 14 Aug 2023.